Live GMP
Aureate Tradde Ltd GMP ₹0 SMR Jewels Ltd GMP ₹0 Hexagon Nutrition Ltd GMP ₹3+6.67% Genxai Analytics Ltd GMP ₹0 Vahh Chemicals Ltd GMP ₹0 CMR Green Technologies Ltd GMP ₹26+13.54% Merritronix Ltd GMP ₹68+45.64% Liotech Industries Ltd. GMP ₹0
Syncom Healthcare Ltd. Logo

Syncom Healthcare Ltd. IPO

Closed Bookbuilding IPO NSE & BSE Fresh Capital
← Back to GMP
Issue Price ₹75
GMP
Lot Size 90
Face Value ₹10
Issue Size 7,500,000 shares (aggregating up to ₹56 Cr)
Subscription

IPO Timeline

Open Date27-Jan-10
Close Date29-Jan-10
Allotment-
Refund Initiation-
Demat Credit-
UPI Mandate Deadline29-Jan-10
Listing Date15-Feb-10

Category-wise Subscription

Shares offered, bid & amount
CategorySub (x)OfferedBid ForAmt (Cr)*
QIB 3,750,000 (50%) ₹2,813 Cr
NII (HNI) 1,125,000 (15%) ₹844 Cr
Retail 2,625,000 (35%) ₹1,969 Cr
Σ  Total7,500,000 (100%)₹56,250 Cr

Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.

Issue Details

Issue Price / Price Band₹75
Face Value₹10
Lot Size90 shares
Issue Size7,500,000 shares (aggregating up to ₹56 Cr)
Issue TypeBookbuilding IPO
Listing ExchangeNSE & BSE
Sale TypeFresh Capital
Script Code
Net Offer to Public
Amount InLakhs
Stock Price History · BSE
Loading chart data...
H
L
O
Yahoo Finance · Live

Minimum Investment (Lot-wise)

CategoryLotsSharesAmount (₹)
Retail (Min)190₹6,750
Retail (Max)131,170₹87,750
S-HNI (Min)141,260₹94,500
B-HNI (Min)676,030₹452,250
Retail1 lot(s)90 shares₹6,750
S-HNI149 lot(s)13,410 shares₹1,005,750

Shareholding Pattern

Pre-Issue Shareholding10,000,000 shares%
Post-Issue Shareholding17,500,000 shares%
Reserved for Market Maker

Financial Statements Amount in Lakhs

Metric 31-Jul-09 31-Mar-09 31-Mar-08
Revenue 2,068 6,056 5,495
Profit After Tax 160 378 367

Valuation & Key Ratios

ROE
ROCE
RONW18%
PAT Margin
EBITDA Margin
Debt/Equity
P/BV
Pre EPS
Post EPS
Pre P/E
Post P/E

Grey Market Premium (GMP)

Current GMP

GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.

Objects of the Issue

  • 1 To set up our new manufacturing unit at Indore SEZ – 20.480
  • 2 To undertake the Upgradation/modernization of manufacturing facilities at Dehradun Plant – 6.620
  • 3 To meet Working Capital Requirements – 15.000
  • 4 For opening Export Office at Mumbai – 4.000
  • 5 For ìBrand & Product Registration and Approvalî – 3.000
  • 6 General Corporate Purpose – 2.923
  • 7 Issue Expenses – 5.468

Company Overview

Incorporated in 2002, Syncom Healthcare Ltd is a pharmaceutical company based in central India. Syncom is in the business of manufacturing, marketing & trading of pharmaceuticals formulations under its own brands of Ethical, OTC, Generic and Herbal market segment. Syncom have over 250 products available in various dosage forms including Tablets, Capsules, Liquids, Ointments, Eye/Ear Drops, Dry Syrup, Herbal Products, Protein Powder and External Preparations.

Apart from their own Marketing setup (OTC, Generics and Ethical Divisions), Syncom Healthcare is also a leading Contract Manufacturing company catering to various domestic and multinational companies. Syncom have a range of over 400 products and can develop customized products as per the needs of the customer and deliver the products at short notice. Syncom Healthcare manufacturing premises spans is over 1,25,000 sq.fts.

The proceeds of the issue are proposed to be utilized for its various expansion plan which include setting up of a new manufacturing unit at Indore SEZ for manufacturing various pharmaceutical formulations, undertaking various upgradation/modernization of manufacturing facilities at Dehradun plant and to set up an export office at Mumbai.

Company Information

Address221, Vyapar Bhawan, P.D'Mello Road, Mumbai - 400009 Mumbai, Maharashtra